Diabetes Drugs

DIABETES DRUG LAWSUITS

Type 2 diabetes is a serious disease that affects approximately 29 million people, or 9.3% of the population, in the United States.  There are a variety of medications available to diabetics to help control their blood glucose levels.  Prescription medications designed to treat Type 2 diabetes control blood glucose levels in patients in different ways.  Some of these medications stimulate the release of certain chemicals in the brain and pancreas to help improve blood glucose levels.  Other medications work by reducing the amount of insulin that can be absorbed by the liver.  Scientific studies have linked several Type 2 diabetes medications to serious side effects like etoacidosis, heart failure and certain types of cancer.

Diabetes Drugs we are Investigating

The attorneys at Franklin D. Azar and Associates are investigating the following diabetes drugs:

  • Actos® – In 2010 the FDA issued a Safety Announcement regarding the correlation between Actos use and the development of bladder cancer.
  • Onglyza® – In 2016 the FDA issued a Safety Announcement regarding the correlation between Onglyza use and an increased risk of heart failure.
  • Invokana® – In 2015 the FDA issued a Safety Announcement regarding the correlation between SGLT2 Inhibitors, like Invokana®, and ketoacidosis, a dangerous condition in which the patient’s blood becomes too acidic.

If you were injured as a result of taking one of these drugs, call our firm today for a free consultation.